5-Alpha-Reductase Inhibitors for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Obstruction
November 2015
in “
Cochrane library
”
![Image of study](/images/research/7422c8fa-fc86-4e02-8280-7144c4f3eb04/medium/28645.jpg)
TLDR 5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.
This protocol for a Cochrane Review aimed to evaluate the effectiveness of 5-alpha-reductase inhibitors (5ARIs) in treating lower urinary tract symptoms (LUTS) caused by benign prostatic obstruction (BPO).